Who founded Neurovalens?

Neurovalens was founded by Dr. Jason McKeown.

Who are Neurovalens's investors?

Neurovalens's investors include Clarendon Fund Managers Ltd., IQ Capital, ACF Investors, Beltrae Partners, British Business Bank, Invest Northern Ireland, Techstart Ventures.

Where is Neurovalens headquartered?

Neurovalens is headquartered in Northern Ireland, GB.

Neurovalens

Northern Ireland, GB · 11 known investors

Find your way into Neurovalens

Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders. The company conducts research and development activities supported by European funding programs.

Biotech Deep Tech Healthtech Medical Devices Mental Health

Founders & leadership

Dr. Jason McKeownMD PhD, Founder

Investors · 11

Clarendon Fund Managers Ltd.listed by Clarendon Fund Managers Ltd.Belfast · $63K – $3.8M

How we know: Clarendon Fund Managers Ltd.'s portfolio page · Not right? Tell us

IQ Capitallisted by IQ CapitalLondon · $1M – $40M

How we know: IQ Capital's portfolio page · uktech.news · funding news · the VCSheet dataset · Not right? Tell us

ACF InvestorsreportedSheffield · $125K – $1.3M

How we know: a partner's Signal profile · Not right? Tell us

Beltrae PartnersreportedBelfast · $1M – $15M

How we know: uktech.news · funding news · Not right? Tell us

British Business BankreportedSheffield

How we know: uktech.news · funding news · Not right? Tell us

Invest Northern IrelandreportedBelfast

How we know: uktech.news · funding news · Not right? Tell us

Techstart VenturesreportedEdinburgh · $950K

How we know: uktech.news · funding news · Not right? Tell us

Also in the syndicate · 4

Angel Co FundClarendon Fund ManagementMedTech InnovatorWharton Asset Management

Funding

SEC filings, press & company announcements

Undisclosed amountfunding roundApr 2024
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗

Registered name: NEUROVALENS LIMITED
Company number: NI617853
Status: Active
Company type: Private limited company
Incorporated: 12 Apr 2013
Registered office: 8 Carmagrim Road, Portglenone, Ballymena, County Antrim, BT44 8BP
Nature of business (SIC): 27900 — Manufacture of other electrical equipment72110 — Research and experimental development on biotechnology86900 — Other human health activities
Accounts: last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement: last made up to 12 Apr 2026 · next due 26 Apr 2027

Current officers · 7

Robert Andrew Brian Cummings — director, appointed 11 Jul 2025
Ian David Victor Kerr — director, appointed 28 Jun 2017
Tina Liedtky — director, appointed 28 Sept 2021
Jason Mckeown — director, appointed 12 Apr 2013
Gaby Salem — director, appointed 15 Jan 2019
Jeffrey Smith — director, appointed 11 Jul 2025
Iq Capital Directors Nominees Limited — corporate director, appointed 11 Sept 2020

Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Neurovalens Receives Research Funding to Advance Health Techneurovalens.com

Frequently asked questions

What does Neurovalens do?: Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders. The company conducts research and development activities supported by European funding programs.
Who founded Neurovalens?: Neurovalens was founded by Dr. Jason McKeown.
Who are Neurovalens's investors?: Neurovalens's investors include Clarendon Fund Managers Ltd., IQ Capital, ACF Investors, Beltrae Partners, British Business Bank, Invest Northern Ireland, Techstart Ventures.
Where is Neurovalens headquartered?: Neurovalens is headquartered in Northern Ireland, GB.